Rogers Corp. engages in the design, development, manufacture, and sale of engineered materials and components for mission critical applications. It operates through the following segments: Advanced Electronics Solutions (AES) and Elastomeric Material Solutions (EMS), and Other. The AES segment manufactures and sells circuit materials, ceramic substrate materials, busbars and cooling solutions for applications in electric and hybrid electric vehicles, wireless infrastructure, automotive, telematics and thermal solutions, aerospace and defense, mass transit, clean energy, connected devices and wired infrastructures. The EMS segment consists of elastomeric material solutions for critical cushioning, gasketing and sealing, impact protection, and vibration management applications. The Other segment consists of elastomer components for applications in ground transportation, office equipment, consumer and other markets. The company was founded by Peter Rogers in 1832 and is headquartered in Chandler, AZ.
Market Cap
$1.88B
P/E Ratio
37.85
1Y Stock Return
-23.03%
1Y Revenue Growth
-9.17%
Dividend Yield
0.00%
Price to Book
1.4
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CPSH | -0.02% | $20.70M | -40.13% | 0.00% |
ED | 0.03% | $33.59B | +7.16% | 3.43% |
EDSA | 0.06% | $7.11M | -21.79% | 0.00% |
JNJ | -0.17% | $368.37B | +1.24% | 3.18% |
PRAX | 0.21% | $1.36B | +353.27% | 0.00% |
ALNY | 0.23% | $30.22B | +43.13% | 0.00% |
QNRX | -0.27% | $3.20M | -85.07% | 0.00% |
PEP | 0.52% | $215.02B | -6.60% | 3.35% |
PRPH | -0.54% | $18.14M | -82.61% | 0.00% |
BCAN | 0.63% | $72.87M | -99.75% | 0.00% |
SO | 0.64% | $96.74B | +26.76% | 3.24% |
WM | 0.74% | $87.92B | +27.58% | 1.34% |
RSG | 0.76% | $66.05B | +31.79% | 1.04% |
UUU | 0.77% | $4.97M | -41.89% | 0.00% |
DXCM | 0.80% | $29.25B | -31.28% | 0.00% |
MANU | 0.84% | $2.88B | -9.41% | 0.00% |
AMLX | 0.90% | $357.82M | -58.70% | 0.00% |
NXTC | 1.03% | $36.69M | +6.50% | 0.00% |
NHTC | -1.20% | $61.83M | +0.19% | 14.81% |
JNPR | -1.23% | $11.61B | +30.55% | 2.49% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VSH | 63.13% | $2.07B | -31.61% | 2.64% |
SCL | 62.86% | $1.69B | -6.79% | 2.01% |
NOVT | 61.57% | $5.95B | +15.14% | 0.00% |
KWR | 60.84% | $2.91B | -5.30% | 1.14% |
CTS | 60.61% | $1.58B | +33.53% | 0.30% |
MTX | 60.46% | $2.54B | +28.39% | 0.52% |
AVNT | 60.44% | $4.56B | +44.78% | 2.08% |
MOG.A | 60.28% | $6.98B | +60.59% | 0.51% |
KN | 60.22% | $1.60B | +12.19% | 0.00% |
TROW | 59.29% | $26.20B | +21.60% | 4.19% |
NPO | 59.19% | $3.64B | +36.09% | 0.69% |
KFRC | 59.15% | $1.10B | -8.71% | 0.66% |
LFUS | 59.11% | $5.90B | +1.26% | 1.12% |
KALU | 59.06% | $1.29B | +34.50% | 3.84% |
AIN | 58.37% | $2.61B | -0.13% | 1.26% |
ALG | 58.10% | $2.30B | +4.01% | 0.55% |
AN | 57.78% | $6.53B | +24.16% | 0.00% |
IOSP | 57.64% | $2.91B | +9.50% | 1.32% |
AEIS | 57.49% | $4.20B | +16.90% | 0.27% |
FLS | 57.36% | $7.89B | +58.40% | 1.38% |
Current Value
$100.221 Year Return
Current Value
$100.221 Year Return
Yahoo
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE Mark for its VENTANA® FOLR1 (FOLR1-2.1) RxDx Assay. This is the first immunohistochemistry (IHC) companion diagnostic test to be made widely available in Europe to aid in identifying epithelial ovarian cancer (EOC) patients who may be eligible for targeted treatment with ELAHERE® (mirvetuximab soravtansine). ELAHERE is a first-in-class antibody-drug conjugate (ADC) therapy developed by AbbVie for the treatment of FRɑ-posi
Yahoo
The subdued market reaction suggests that Rogers Corporation's ( NYSE:ROG ) recent earnings didn't contain any...
Yahoo
Rogers ( NYSE:ROG ) Third Quarter 2024 Results Key Financial Results Revenue: US$210.3m (down 8.2% from 3Q 2023). Net...
Yahoo
Q3 2024 Rogers Corp Earnings Call
Yahoo
Despite revenue setbacks, Rogers Corp (ROG) exceeds earnings expectations and focuses on long-term growth in emerging markets.
SeekingAlpha
Rogers Corporation (NYSE:ROG) Q3 2024 Earnings Call Transcript October 24, 2024 5:00 PM ETCompany ParticipantsSteve Haymore - Director, Investor...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -28.33% | $21.46B | +15.84% | 1.11% |
MCK | -12.46% | $78.15B | +35.51% | 0.42% |
PGR | -12.35% | $149.10B | +57.29% | 0.45% |
COR | -11.99% | $47.48B | +21.20% | 0.86% |
MNR | -11.99% | $1.66B | -10.71% | 15.90% |
HUSA | -11.92% | $16.69M | -11.56% | 0.00% |
NOC | -10.86% | $71.54B | +4.23% | 1.60% |
ABBV | -10.38% | $294.35B | +20.07% | 3.72% |
CHD | -10.11% | $27.18B | +19.50% | 1.03% |
NEUE | -10.06% | $40.93M | -34.13% | 0.00% |
MNOV | -8.44% | $93.19M | +2.15% | 0.00% |
PRPO | -8.24% | $9.10M | -13.65% | 0.00% |
LTM | -7.90% | $8.51B | -100.00% | <0.01% |
CPB | -7.58% | $12.96B | +7.08% | 3.40% |
KNSL | -7.18% | $10.93B | +29.38% | 0.13% |
BTCT | -7.05% | $42.61M | +353.33% | 0.00% |
QTTB | -6.86% | $354.34M | +188.64% | 0.00% |
CME | -6.84% | $82.76B | +9.21% | 1.98% |
LMT | -6.72% | $126.40B | +18.99% | 2.36% |
STG | -6.36% | $35.67M | +7.92% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -52.43% | $388.04M | 1.43% |
VIXY | -35.53% | $195.31M | 0.85% |
TAIL | -27.90% | $67.98M | 0.59% |
USDU | -19.01% | $201.97M | 0.5% |
UUP | -16.01% | $309.25M | 0.77% |
JUCY | -10.55% | $324.29M | 0.6% |
CTA | -9.32% | $350.27M | 0.78% |
SHYD | -7.04% | $311.50M | 0.35% |
WEAT | -6.87% | $120.27M | 0.28% |
EQLS | -6.58% | $76.08M | 1% |
KCCA | -6.00% | $220.51M | 0.87% |
BSCO | -5.72% | $2.35B | 0.1% |
CLOI | -5.26% | $715.40M | 0.4% |
UNG | -5.00% | $908.80M | 1.06% |
KMLM | -4.13% | $353.87M | 0.9% |
TBIL | -3.64% | $4.38B | 0.15% |
CCOR | -2.53% | $109.04M | 1.18% |
CORN | -2.02% | $61.12M | 0.2% |
HDRO | -1.94% | $164.26M | 0.3% |
XHLF | -1.87% | $874.27M | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EFAA | 70.36% | $117.38M | 0% |
IJR | 69.03% | $90.05B | 0.06% |
DFAT | 68.84% | $11.16B | 0.28% |
SPSM | 68.73% | $12.72B | 0.03% |
GSSC | 68.67% | $529.86M | 0.2% |
VIOO | 68.62% | $3.12B | 0.1% |
DFSV | 68.55% | $4.16B | 0.31% |
VXF | 68.50% | $21.54B | 0.06% |
IJT | 68.45% | $6.64B | 0.18% |
EES | 68.20% | $668.71M | 0.38% |
JMEE | 68.19% | $1.51B | 0.24% |
VTWO | 68.18% | $12.38B | 0.1% |
PRFZ | 68.16% | $2.65B | 0.39% |
SLYG | 68.12% | $3.69B | 0.15% |
IWM | 68.10% | $75.73B | 0.19% |
SLYV | 68.02% | $4.16B | 0.15% |
VIOV | 67.95% | $1.44B | 0.15% |
NUSC | 67.81% | $1.27B | 0.31% |
IJS | 67.73% | $7.37B | 0.18% |
PSC | 67.70% | $702.17M | 0.38% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GBIL | -0.15% | $5.60B | 0.12% |
IBTE | -0.24% | $1.70B | 0.07% |
BILZ | -0.48% | $563.02M | 0.14% |
FLRN | 0.73% | $2.33B | 0.15% |
BOXX | -0.85% | $4.43B | 0.1949% |
ULST | 0.96% | $535.47M | 0.2% |
MINT | 1.03% | $11.62B | 0.35% |
XBIL | -1.46% | $637.70M | 0.15% |
CSHI | 1.61% | $482.85M | 0.38% |
XHLF | -1.87% | $874.27M | 0.03% |
HDRO | -1.94% | $164.26M | 0.3% |
CORN | -2.02% | $61.12M | 0.2% |
XONE | 2.16% | $548.88M | 0.03% |
CCOR | -2.53% | $109.04M | 1.18% |
AGZD | 2.91% | $142.76M | 0.23% |
SHV | 3.49% | $18.13B | 0.15% |
TBIL | -3.64% | $4.38B | 0.15% |
SGOV | 3.68% | $27.53B | 0.09% |
IVOL | 3.76% | $548.70M | 1.02% |
DBE | 4.04% | $50.13M | 0.77% |